{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06345794",
            "orgStudyIdInfo": {
                "id": "DCE853103"
            },
            "secondaryIdInfos": [
                {
                    "id": "J5C-MC-FOAG",
                    "type": "OTHER",
                    "domain": "DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company"
                }
            ],
            "organization": {
                "fullName": "DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants",
            "officialTitle": "A Phase 1, Single-Center, Open-Label, 3-Cohort, Fixed-Sequence, Drug-Drug Interaction Study To Assess The Pharmacokinetics Of LY4100511 (DC-853) When Orally Administered Alone, When Coadministered With Itraconazole, Fluconazole, Or Carbamazepine In Healthy Adult Participants",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-assess-dc-in-healthy-adult-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-17",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-28",
            "studyFirstSubmitQcDate": "2024-03-28",
            "studyFirstPostDateStruct": {
                "date": "2024-04-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Eli Lilly and Company",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to assess the effect of multiple doses of itraconazole, fluconazole, and carbamazepine on single dose pharmacokinetic of LY4100511 (DICE-853) in healthy participants. The study will also evaluate the safety and tolerability of LY4100511 (DICE-853) with itraconazole, fluconazole, and carbamazepine."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ],
            "keywords": [
                "DC-853",
                "LY4100511"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LY4100511 (DC-853) + Itraconazole",
                    "type": "EXPERIMENTAL",
                    "description": "Single oral doses of LY4100511 (DC-853) with single and multiple doses of Itraconazole administered orally.",
                    "interventionNames": [
                        "Drug: LY4100511 (DC-853)",
                        "Drug: Itraconazole"
                    ]
                },
                {
                    "label": "LY4100511 (DC-853) + Fluconazole",
                    "type": "EXPERIMENTAL",
                    "description": "Single oral doses of LY4100511 (DC-853) with single and multiple doses of fluconazole administered orally.",
                    "interventionNames": [
                        "Drug: LY4100511 (DC-853)",
                        "Drug: Fluconazole"
                    ]
                },
                {
                    "label": "LY4100511 (DC-853) + Carbamazepine",
                    "type": "EXPERIMENTAL",
                    "description": "Single oral doses of LY4100511 (DC-853) with single and multiple doses of Carbamazepine administered orally.",
                    "interventionNames": [
                        "Drug: LY4100511 (DC-853)",
                        "Drug: Carbamazepine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "LY4100511 (DC-853)",
                    "description": "Administered orally.",
                    "armGroupLabels": [
                        "LY4100511 (DC-853) + Carbamazepine",
                        "LY4100511 (DC-853) + Fluconazole",
                        "LY4100511 (DC-853) + Itraconazole"
                    ],
                    "otherNames": [
                        "DC-853"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Itraconazole",
                    "description": "Administered orally.",
                    "armGroupLabels": [
                        "LY4100511 (DC-853) + Itraconazole"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fluconazole",
                    "description": "Administered orally.",
                    "armGroupLabels": [
                        "LY4100511 (DC-853) + Fluconazole"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Carbamazepine",
                    "description": "Administered orally.",
                    "armGroupLabels": [
                        "LY4100511 (DC-853) + Carbamazepine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pharmacokinetics (PK): Maximum Observed Concentration (Cmax) of LY4100511 (DC-853)",
                    "timeFrame": "Predose up to 26 Days"
                },
                {
                    "measure": "PK: PK: Area Under the Concentration Versus Time Curve From Zero to Last Measurable Concentration (AUC[0-t]) of LY4100511 (DC-853)",
                    "timeFrame": "Predose up to 26 Days"
                },
                {
                    "measure": "PK: Area Under the Concentration Versus Time Curve From Zero to Infinity (AUC[0-inf]) of LY4100511 (DC-853)",
                    "timeFrame": "Predose up to 26 Days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a body mass index within the range of 18.0 to 32 kilograms per square meter (kg/m\u00b2)\n* Males who agree to follow contraceptive requirements and women of not childbearing potential\n* Have body weight greater than or equal to (\\>=) 50 Kilograms at screening.\n* Must have a negative Interferon-Gamma Release Assays (IGRA) testing at screening\n* Must have been stopped all the prescribed medication at least 14 days prior to admission to the clinical site\n* Ability and willingness to abstain from alcohol, caffeine, and methylxanthine-containing beverages or food 2 days prior to admission to the clinical site\n* Abstain from any strenuous physical exercise from 4 days prior to admission and during confinement at the clinical site\n\nExclusion Criteria:\n\n* Have a history of relevant drug and/or food allergies, or sensitivity to medications used in the current study\n* Females participants who are currently breastfeeding\n* Have History of alcohol abuse or drug addiction\n* Unable to abstain from tobacco products within the 2 days prior to admission and during confinement at the clinical site\n* Have Positive screen for hepatitis B surface antigen, hepatitis C virus (HCV) antibodies, or human immunodeficiency virus (HIV) 1 and 2 antibodies\n* Consumption of any nutrients known to modulate CYP450 enzymes activity\n* Are immunocompromised\n* Have received live vaccine(s) (including attenuated live vaccines) or Bacillus Calmette-Gu\u00e9rin within 28 days of screening or intend to receive them during the study\n* Have had any malignancy within the past 5 years",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "This is a single site clinical trial 1-877-CTLILLY (1-877-285-4559) or",
                    "role": "CONTACT",
                    "phone": "13176154559",
                    "email": "ClinicalTrials.gov@lilly.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Contact Lilly at 1-800-LillyRx (1-800-545-5979)",
                    "affiliation": "Eli Lilly and Company",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "ICON San Antonio Clinical Research Unit",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78209",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "210-283-4500"
                        },
                        {
                            "name": "Chinonye Ogbonnaya-Odor",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017964",
                    "term": "Itraconazole"
                },
                {
                    "id": "D000015725",
                    "term": "Fluconazole"
                },
                {
                    "id": "D000002220",
                    "term": "Carbamazepine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000935",
                    "term": "Antifungal Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000058888",
                    "term": "14-alpha Demethylase Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000065088",
                    "term": "Steroid Synthesis Inhibitors"
                },
                {
                    "id": "D000006727",
                    "term": "Hormone Antagonists"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000065692",
                    "term": "Cytochrome P-450 CYP3A Inhibitors"
                },
                {
                    "id": "D000065688",
                    "term": "Cytochrome P-450 CYP2C9 Inhibitors"
                },
                {
                    "id": "D000065689",
                    "term": "Cytochrome P-450 CYP2C19 Inhibitors"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000018692",
                    "term": "Antimanic Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000065701",
                    "term": "Cytochrome P-450 CYP3A Inducers"
                },
                {
                    "id": "D000065693",
                    "term": "Cytochrome P-450 Enzyme Inducers"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20133",
                    "name": "Itraconazole",
                    "asFound": "Fixed dose",
                    "relevance": "HIGH"
                },
                {
                    "id": "M256158",
                    "name": "Hydroxyitraconazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M5480",
                    "name": "Carbamazepine",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18296",
                    "name": "Fluconazole",
                    "asFound": "Office",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6252",
                    "name": "Clotrimazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M11796",
                    "name": "Miconazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M4254",
                    "name": "Antifungal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M30564",
                    "name": "Cytochrome P-450 CYP3A Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                }
            ]
        }
    },
    "hasResults": false
}